Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels.

MRÁZ, Marek. Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels. In ESH Translational Research E-Conference. 2021.

Basic information

• Original name: Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels.
• Authors: MRÁZ, Marek.
• Edition: ESH Translational Research E-Conference, 2021.

Other information

• Type of outcome: Conference abstract
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology